Bing

SEARCH HISTORY

The U.S. Food and Drug Administration (FDA) declined to approve Northera, CHTP’s blood pressure treatment, in 2012. CHTP resubmitted the drug in September. A research note from analysts at Wedbush indicated that an FDA advisory panel recently …
Investor Place · ByChristopher Freeburn · 1/16/2014
This reverses the recent trend for CHTP, as the stock is now up over 12% since Jan 15. This pharmaceutical company has seen a flat track record when it comes to current year estimate revisions over the past few weeks, and the consensus for earnings …
Yahoo Finance · 2/14/2014
After Rockwell Medical Inc (NASDAQ:RMTI) stock was lifted to Buy and price target $22 at Chardan Capital Markets. Rockwell Medical Inc (NASDAQ:RMTI) shares rose 5.99%, to end at $11.15. Chelsea Therapeutics International Ltd. (NASDAQ:CHTP) …
fxnewscall.com · 12/20/2013
More from Bing News
Investors like to buy the stocks at a rock bottom price that have growth potential ... Chelsea Therapeutics International Ltd (NASDAQ:CHTP): Chelsea Therapeutics is a development stage pharmaceutical company that focuses on acquiring, developing and ...
Seeking Alpha · 5/11/2012
Chelsea Therapeutics International Ltd. ( CHTP) saw a big move last session, as the company's shares fell by over 7% on the day. The move came on pretty good volume too with far more shares changing hands than in a normal session. This reverses the …
NASDAQ · 2/14/2014
Investors in Chelsea Therapeutics International Ltd (CHTP) saw new options begin trading this week, for the May 17th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the CHTP options chain for the new May 17th …
The Street · 3/27/2014
On Tuesday, small cap Chelsea Therapeutics International fell 8% to $2.30 (CHTP has a 52 week trading range of $0.76 to $4.53 a share) for a market cap of $180.40 million, but the stock is set to rise as much as 123% when it opens on Wednesday.
Smallcap Network · ByJohn Udovich · 1/15/2014
The start of the annual Paris Air Show creates an opportune moment to talk about one of our favorite long-term investments: The Boeing Co. (NYSE: BA). Shares of the commercial jetliner firm have soared nearly 130% since we first recommended them in ...
Money Morning · 1/18/2014
Charlotte NC-based Chelsea Therapeutics (NASDAQ:CHTP, Stock Forum) has announced its Northera (droxidopa) product has won accelerated approval by the US Food and Drug Administration (FDA). A decision regarding approval of the drug was …
Stockhouse · 2/18/2014
Zale Corporation (NYSE: ZLC) 40% HIGHER; Signet Jewelers Limited (NYSE: SIG) and Zale Corporation (NYSE: ZLC) announced that they have entered into a definitive agreement for Signet to acquire all of the issued and outstanding stock of Zale for $21.
StreetInsider · 2/19/2014